CD9 and Alzheimer disease: When serum was extracted by IPA, neither TGs nor phospholipid profiles seemed to differ significantly among the five diseases, but when serum was enriched with CD9 antibody magnetic beads, TGs (Figure 8) and PCs (Figure S3) in Alzheimer’s disease and major depression seemed to be lower than those in the other three diseases.